AGRI Announces Strategic Alliance with Latin America Clinical Research Alliance (LACRA) to Expand Global Network of Sites to Latin America
January 21, 2014 Health News(PRLEAP.COM) January 21, 2014 - The Atlantis Global Research Institute (AGRI) today announced that it will partner with Latin America Clinical Research Alliance (LACRA), a division of Interventional Concepts (collectively, IC), to expand AGRI's global network of clinical research sites to Latin America. As a result AGRI and IC will be able to provide the biomedical, device and diagnostic industries with over 100 multi-therapeutic government-approved clinical research sites in various countries in Latin America, with an initial focus in Colombia.
IC and LACRA President and CEO, Julio Martinez-Clark, noted, "The development of our partnership is a testament to our vision of developing Latin America, starting with Colombia, into an excellent location to conduct clinical research. AGRI's sponsors will have access to over 100 sites and IC's extensive regulatory, transportation, importation, logistics and distribution capabilities in Colombia. We are excited to be joining forces with Atlantis Global Research Institute as we share the belief that Latin America represents an untapped opportunity for the medical device and biopharma companies."
We are beyond excited to partner with Interventional Concept's to expand AGRI's Global Network to Latin America, said AGRI's President and Managing Director, Robert Wallace. "We see this as a great opportunity for our industry partners to conduct their trials at ethical, high-quality, high-volume research sites."
Atlantis Global Research Institute (AGRI) is pioneering changes in how global clinical research is conducted by developing synergistic partnerships, collaborations, and alliances to produce quality results in a more timely and cost-efficient manner.
Interventional Concepts, Inc. (IC) was founded in 2010 by Interventional cardiologist, Pedro Martinez-Clark, M.D. IC is a full-service Contract Research Organization (CRO) for the biopharmaceutical and device industries with the capability of guiding companies from proof-of-concept to market. IC works closely with Proexport, the Colombian government's export promoting agency, to position Colombia as one of the premier destination for cost-effective clinical research.